These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates. Banerjee SR; Foss CA; Pullambhatla M; Wang Y; Srinivasan S; Hobbs RF; Baidoo KE; Brechbiel MW; Nimmagadda S; Mease RC; Sgouros G; Pomper MG J Nucl Med; 2015 Apr; 56(4):628-34. PubMed ID: 25722448 [TBL] [Abstract][Full Text] [Related]
4. A gate evaluation of the sources of error in quantitative Strydhorst J; Carlier T; Dieudonné A; Conti M; Buvat I Med Phys; 2016 Oct; 43(10):5320-5329. PubMed ID: 28105711 [TBL] [Abstract][Full Text] [Related]
5. 90Yttrium PET/MR-based dosimetry after liver radioembolization (SIRT). Wissmeyer M; Delattre BM; Zaidi H; Terraz S; Ratib O Clin Nucl Med; 2015 Apr; 40(4):355-7. PubMed ID: 25674869 [TBL] [Abstract][Full Text] [Related]
6. Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours. Helisch A; Förster GJ; Reber H; Buchholz HG; Arnold R; Göke B; Weber MM; Wiedenmann B; Pauwels S; Haus U; Bouterfa H; Bartenstein P Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1386-92. PubMed ID: 15175836 [TBL] [Abstract][Full Text] [Related]
7. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis. Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126 [TBL] [Abstract][Full Text] [Related]
8. Positron Emission Intensity in the Decay of Uddin MS; Qaim SM; Scholten B; Basunia MS; Bernstein LA; Spahn I; Neumaier B Molecules; 2022 Jan; 27(3):. PubMed ID: 35164033 [TBL] [Abstract][Full Text] [Related]
9. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma. Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792 [TBL] [Abstract][Full Text] [Related]
10. (90)Y-PET/CT Imaging Quantification for Dosimetry in Peptide Receptor Radionuclide Therapy: Analysis and Corrections of the Impairing Factors. Fabbri C; Bartolomei M; Mattone V; Casi M; De Lauro F; Bartolini N; Gentili G; Amadori S; Agostini M; Sarti G Cancer Biother Radiopharm; 2015 Jun; 30(5):200-10. PubMed ID: 25860616 [TBL] [Abstract][Full Text] [Related]
11. The production of [124I]iodine and [86Y]yttrium. Schmitz J Eur J Nucl Med Mol Imaging; 2011 May; 38 Suppl 1():S4-9. PubMed ID: 21484376 [TBL] [Abstract][Full Text] [Related]
12. Theranostic Imaging of Yttrium-90. Wright CL; Zhang J; Tweedle MF; Knopp MV; Hall NC Biomed Res Int; 2015; 2015():481279. PubMed ID: 26106608 [TBL] [Abstract][Full Text] [Related]
13. Dosimetry of Y-90 Microspheres Utilizing Tc-99m SPECT and Y-90 PET. Tafti BA; Padia SA Semin Nucl Med; 2019 May; 49(3):211-217. PubMed ID: 30954187 [TBL] [Abstract][Full Text] [Related]
14. Fast simulation of yttrium-90 bremsstrahlung photons with GATE. Rault E; Staelens S; Van Holen R; De Beenhouwer J; Vandenberghe S Med Phys; 2010 Jun; 37(6):2943-50. PubMed ID: 20632606 [TBL] [Abstract][Full Text] [Related]
15. PET tracers based on (86)Y. Huang J; Cui L; Wang F; Liu Z Curr Radiopharm; 2011 Apr; 4(2):122-30. PubMed ID: 22191651 [TBL] [Abstract][Full Text] [Related]
16. 90Y microsphere therapy: does 90Y PET/CT imaging obviate the need for 90Y Bremsstrahlung SPECT/CT imaging? Zade AA; Rangarajan V; Purandare NC; Shah SA; Agrawal AR; Kulkarni SS; Shetty N Nucl Med Commun; 2013 Nov; 34(11):1090-6. PubMed ID: 23942324 [TBL] [Abstract][Full Text] [Related]
17. Comparison of PMT-based TF64 and SiPM-based Vereos PET/CT systems for Trotta N; Collette B; Mathey C; Vierasu I; Bucalau AM; Verset G; Moreno-Reyes R; Goldman S Med Phys; 2022 Dec; 49(12):7567-7582. PubMed ID: 35894818 [TBL] [Abstract][Full Text] [Related]
18. Uptake kinetics of the somatostatin receptor ligand [86Y]DOTA-DPhe1- Tyr3-octreotide ([86Y]SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90Y-labelled analogue. Rösch F; Herzog H; Stolz B; Brockmann J; Köhle M; Mühlensiepen H; Marbach P; Müller-Gärtner HW Eur J Nucl Med; 1999 Apr; 26(4):358-66. PubMed ID: 10199941 [TBL] [Abstract][Full Text] [Related]
19. Quantitative comparison of pre-therapy Knešaurek K; Tuli A; Pasik SD; Heiba S; Kostakoglu L Eur J Radiol; 2018 Dec; 109():57-61. PubMed ID: 30527312 [TBL] [Abstract][Full Text] [Related]